Search | VHL Search Portal

1.

Long-acting cabotegravir pharmacokinetics with and without oral lead-in for HIV PrEP.

Han, Kelong; Patel, Parul; McCallister, Scott; Rinehart, Alex R; Gandhi, Yash; Spreen, William; Landovitz, Raphael J; Delany-Moretlwe, Sinead; Marzinke, Mark A; McKeon, Todd; Budnik, Piotr; van Wyk, Jean; Ford, Susan L.

Antimicrob Agents Chemother ; : e0147523, 2024 May 06.

Article in English | MEDLINE | ID: mdl-38709006

2.

Demographic diversity of US-based participants in GSK-sponsored interventional clinical trials.

Reid, Michel M; Davis, Scott P; Henry, Ouzama N; Mathew, Ashwin A; McCallister, Scott; Nero, Taj T; Rabheru, Sanjit A; Sampson, Shani H; Vanderslice, Tracy F; Williams, Danaé T.

Clin Trials ; 20(2): 133-144, 2023 04.

Article in English | MEDLINE | ID: mdl-36744680

3.

Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.

Mayer, Kenneth H; Molina, Jean-Michel; Thompson, Melanie A; Anderson, Peter L; Mounzer, Karam C; De Wet, Joss J; DeJesus, Edwin; Jessen, Heiko; Grant, Robert M; Ruane, Peter J; Wong, Pamela; Ebrahimi, Ramin; Zhong, Lijie; Mathias, Anita; Callebaut, Christian; Collins, Sean E; Das, Moupali; McCallister, Scott; Brainard, Diana M; Brinson, Cynthia; Clarke, Amanda; Coll, Pep; Post, Frank A; Hare, C Bradley.

Lancet ; 396(10246): 239-254, 2020 07 25.

Article in English | MEDLINE | ID: mdl-32711800

4.

Evidence of an Association of Increases in Pre-exposure Prophylaxis Coverage With Decreases in Human Immunodeficiency Virus Diagnosis Rates in the United States, 2012-2016.

Smith, Dawn K; Sullivan, Patrick S; Cadwell, Betsy; Waller, Lance A; Siddiqi, Azfar; Mera-Giler, Robertino; Hu, Xiaohong; Hoover, Karen W; Harris, Norma S; McCallister, Scott.

Clin Infect Dis ; 71(12): 3144-3151, 2020 12 15.

Article in English | MEDLINE | ID: mdl-32097453

5.

Efficacy of Oral Tenofovir Alafenamide/Emtricitabine Combination or Single-Agent Tenofovir Alafenamide Against Vaginal Simian Human Immunodeficiency Virus Infection in Macaques.

Massud, Ivana; Cong, Mian-Er; Ruone, Susan; Holder, Angela; Dinh, Chuong; Nishiura, Kenji; Khalil, George; Pan, Yi; Lipscomb, Jonathan; Johnson, Ryan; Deyounks, Frank; Rooney, James F; Babusis, Darius; Park, Yeojin; McCallister, Scott; Callebaut, Christian; Heneine, Walid; García-Lerma, J Gerardo.

J Infect Dis ; 220(11): 1826-1833, 2019 10 22.

Article in English | MEDLINE | ID: mdl-31362305

6.

Gender Parity in Clinical PrEP Trials.

Brainard, Diana M; McCallister, Scott.

N Engl J Med ; 381(26): 2585, 2019 12 26.

Article in English | MEDLINE | ID: mdl-31881150

7.

Single-dose pharmacokinetics of tenofovir alafenamide and its active metabolite in the mucosal tissues.

Cottrell, Mackenzie L; Garrett, Katy L; Prince, Heather M A; Sykes, Craig; Schauer, Amanda; Emerson, Cindi W; Peery, Anne; Rooney, James F; McCallister, Scott; Gay, Cynthia; Kashuba, Angela D M.

J Antimicrob Chemother ; 72(6): 1731-1740, 2017 06 01.

Article in English | MEDLINE | ID: mdl-28369415

8.

Concordance of HIV-1 RNA Values by Amplicor and TaqMan 2.0 in Patients With Confirmed Suppression in Clinical Trials.

Garner, Will; White, Kirsten; Szwarcberg, Javier; McCallister, Scott; Zhong, Lijie; Wulfsohn, Mike.

Clin Infect Dis ; 62(7): 929-934, 2016 Apr 01.

Article in English | MEDLINE | ID: mdl-26689956

9.

Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials.

Sax, Paul E; Wohl, David; Yin, Michael T; Post, Frank; DeJesus, Edwin; Saag, Michael; Pozniak, Anton; Thompson, Melanie; Podzamczer, Daniel; Molina, Jean Michel; Oka, Shinichi; Koenig, Ellen; Trottier, Benoit; Andrade-Villanueva, Jaime; Crofoot, Gordon; Custodio, Joseph M; Plummer, Andrew; Zhong, Lijie; Cao, Huyen; Martin, Hal; Callebaut, Christian; Cheng, Andrew K; Fordyce, Marshall W; McCallister, Scott.

Lancet ; 385(9987): 2606-15, 2015 Jun 27.

Article in English | MEDLINE | ID: mdl-25890673

10.

Rare emergence of drug resistance in HIV-1 treatment-naïve patients after 48 weeks of treatment with elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide.

Margot, Nicolas A; Kitrinos, Kathryn M; Fordyce, Marshall; McCallister, Scott; Miller, Michael D; Callebaut, Christian.

HIV Clin Trials ; 17(2): 78-87, 2016 Mar.

Article in English | MEDLINE | ID: mdl-26892863

11.

Tenofovir Alafenamide for HIV Preexposure Prophylaxis.

Brainard, Diana; McCallister, Scott.

Ann Intern Med ; 173(1): 77-78, 2020 07 07.

Article in English | MEDLINE | ID: mdl-32628874

12.

Combination therapy with telaprevir for chronic hepatitis C virus genotype 1 infection in patients with HIV: a randomized trial.

Sulkowski, Mark S; Sherman, Kenneth E; Dieterich, Douglas T; Bsharat, Mohammad; Mahnke, Lisa; Rockstroh, Jürgen K; Gharakhanian, Shahin; McCallister, Scott; Henshaw, Joshua; Girard, Pierre-Marie; Adiwijaya, Bambang; Garg, Varun; Rubin, Raymond A; Adda, Nathalie; Soriano, Vincent.

Ann Intern Med ; 159(2): 86-96, 2013 Jul 16.

Article in English | MEDLINE | ID: mdl-23685940

13.

Safety and Pharmacokinetics of a Tenofovir Alafenamide Fumarate-Emtricitabine based Oral Antiretroviral Regimen for Prevention of HIV Acquisition in Women: A Randomized Controlled Trial.

Thurman, Andrea R; Schwartz, Jill L; Cottrell, Mackenzie L; Brache, Vivian; Chen, Beatrice A; Cochón, Leila; Ju, Susan; McGowan, Ian; Rooney, James F; McCallister, Scott; Doncel, Gustavo F.

EClinicalMedicine ; 36: 100893, 2021 Jun.

Article in English | MEDLINE | ID: mdl-34041459

14.

Pharmacokinetic characterization of three doses of tipranavir boosted with ritonavir on highly active antiretroviral therapy in treatment-experienced HIV-1 patients.

Goebel, Frank D; MacGregor, Thomas R; Sabo, John P; Castles, Mark; Johnson, Philip A; Legg, Daniel; McCallister, Scott.

HIV Clin Trials ; 11(1): 28-38, 2010.

Article in English | MEDLINE | ID: mdl-20400409

15.

Policy- and county-level associations with HIV pre-exposure prophylaxis use, the United States, 2018.

Siegler, Aaron J; Mehta, C Christina; Mouhanna, Farah; Giler, Robertino Mera; Castel, Amanda; Pembleton, Elizabeth; Jaggi, Chandni; Jones, Jeb; Kramer, Michael R; McGuinness, Pema; McCallister, Scott; Sullivan, Patrick S.

Ann Epidemiol ; 45: 24-31.e3, 2020 05.

Article in English | MEDLINE | ID: mdl-32336655

16.

Methods for county-level estimation of pre-exposure prophylaxis coverage and application to the U.S. Ending the HIV Epidemic jurisdictions.

Sullivan, Patrick S; Mouhanna, Farah; Mera, Robertino; Pembleton, Elizabeth; Castel, Amanda D; Jaggi, Chandni; Jones, Jeb; Kramer, Michael R; McGuinness, Pema; McCallister, Scott; Siegler, Aaron J.

Ann Epidemiol ; 44: 16-30, 2020 04.

Article in English | MEDLINE | ID: mdl-32088073

17.

Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study.

Yager, Jenna; Castillo-Mancilla, Jose; Ibrahim, Mustafa E; Brooks, Kristina M; McHugh, Cricket; Morrow, Mary; McCallister, Scott; Bushman, Lane R; MaWhinney, Samantha; Kiser, Jennifer J; Anderson, Peter L.

J Acquir Immune Defic Syndr ; 84(3): 323-330, 2020 07 01.

Article in English | MEDLINE | ID: mdl-32539288

18.

Atherosclerotic Cardiovascular Disease Risk Profile of Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate.

Huhn, Gregory D; Shamblaw, David J; Baril, Jean-Guy; Hsue, Priscilla Y; Mills, Brittany L; Nguyen-Cleary, Thai; McCallister, Scott; Das, Moupali.

Open Forum Infect Dis ; 7(1): ofz472, 2020 Jan.

Article in English | MEDLINE | ID: mdl-31950070

19.

Estimation of new HIV diagnosis rates among high-risk, PrEP-eligible individuals using HIV surveillance data at the Metropolitan Statistical Area level in the United States.

Mera, Robertino; Scheer, Susan; Carter, Christoph; Das, Moupali; Asubonteng, Julius; McCallister, Scott; Baeten, Jared.

J Int AIDS Soc ; 22(12): e25433, 2019 12.

Article in English | MEDLINE | ID: mdl-31860171

20.

Plasma concentration of neurofilament light chain protein decreases after switching from tenofovir disoproxil fumarate to tenofovir alafenamide fumarate.

Hermansson, Linn; Yilmaz, Aylin; Price, Richard W; Nilsson, Staffan; McCallister, Scott; Makadzange, Tariro; Das, Moupali; Zetterberg, Henrik; Blennow, Kaj; Gisslen, Magnus.

PLoS One ; 14(12): e0226276, 2019.

Article in English | MEDLINE | ID: mdl-31826005

VHL Search Portal

Information and Knowledge for Health

Config filters

Your selection (0)

Export format:

Export: